Published in J Rheumatol on March 01, 1993
Influence of pregnancy on disease activity in a patient with palindromic rheumatism. J Rheumatol (1992) 1.38
EULAR evidence-based recommendations for cardiovascular risk management in patients with rheumatoid arthritis and other forms of inflammatory arthritis. Ann Rheum Dis (2009) 5.82
Vitamin D levels and response to biphosphonates in postmenopausal women receiving glucocorticoid therapy. Osteoporos Int (2014) 5.05
Anti-tumor necrosis factor-alpha blockade improves insulin resistance in patients with rheumatoid arthritis. Clin Exp Rheumatol (2006) 2.80
The STAT4 gene influences the genetic predisposition to systemic sclerosis phenotype. Hum Mol Genet (2009) 1.73
Epidemiology of vasculitis in Europe. Ann Rheum Dis (2001) 1.58
Localized vasculitis in the calf mimicking deep venous thrombosis. Rheumatology (Oxford) (2002) 1.56
Microscopic polyangiitis following recurrent Staphylococcus aureus bacteremia and infectious endocarditis. Clin Exp Rheumatol (2007) 1.54
[Desensitization to rifampicin. Apropos of a case]. Med Clin (Barc) (1996) 1.40
Could HLA-DRB1 be the protective locus in rheumatoid arthritis? Immunol Today (1995) 1.38
HLA-DRB1 alleles encoding an aspartic acid at position 70 protect against development of rheumatoid arthritis. J Rheumatol (2001) 1.25
Geoepidemiology of systemic vasculitis: comparison of the incidence in two regions of Europe. Ann Rheum Dis (2001) 1.21
Short-term adalimumab therapy improves endo-thelial function in patients with rheumatoid arthritis refractory to infliximab. Clin Exp Rheumatol (2006) 1.20
Influence of anti-TNF-alpha infliximab therapy on adhesion molecules associated with atherogenesis in patients with rheumatoid arthritis. Clin Exp Rheumatol (2006) 1.13
The clinical spectrum of osteoarticular tuberculosis in non-human immunodeficiency virus patients in a defined area of northwestern Spain (1988-1997). Clin Exp Rheumatol (2000) 1.07
Interleukin-6 gene -174 promoter polymorphism is associated with endothelial dysfunction but not with disease susceptibility in patients with rheumatoid arthritis. Clin Exp Rheumatol (2010) 1.07
Giant cell arteritis with an erythrocyte sedimentation rate lower than 50. Clin Rheumatol (2000) 1.00
Unilateral submandibular swelling as unique presentation of Wegener's granulomatosis. Rheumatology (Oxford) (2001) 0.99
Association of ferritin autoantibodies with giant cell arteritis/polymyalgia rheumatica. Ann Rheum Dis (2012) 0.95
A large multicentre analysis of CTGF -945 promoter polymorphism does not confirm association with systemic sclerosis susceptibility or phenotype. Ann Rheum Dis (2008) 0.95
Metabolic syndrome in patients with systemic lupus erythematosus from Southern Spain. Lupus (2008) 0.95
Evidence that deletion at FCGR3B is a risk factor for systemic sclerosis. Genes Immun (2012) 0.92
Giant cell arteritis and polymyalgia rheumatica can be differentiated by distinct patterns of HLA class II association. J Rheumatol (1998) 0.91
Late-onset systemic lupus erythematosus in Northwestern Spain: differences with early-onset systemic lupus erythematosus and literature review. Lupus (2012) 0.91
Listeria monocytogenes infection in patients with rheumatic diseases on TNF-alpha antagonist therapy: the Spanish Study Group experience. Clin Exp Rheumatol (2008) 0.90
Genistein-induced cell cycle arrest and apoptosis in a head and neck squamous cell carcinoma cell line. Nutr Cancer (1999) 0.90
Anti-tumour necrosis factor alpha therapy modulates ghrelin in patients with severe rheumatoid arthritis. Ann Rheum Dis (2008) 0.89
A rare polymorphism in the gene for Toll-like receptor 2 is associated with systemic sclerosis phenotype and increases the production of inflammatory mediators. Arthritis Rheum (2012) 0.89
The interleukin 23 receptor gene does not confer risk to systemic sclerosis and is not associated with systemic sclerosis disease phenotype. Ann Rheum Dis (2008) 0.89
HLA-DRB1*01 association with Henoch-Schönlein purpura in patients from northwest Spain. J Rheumatol (2001) 0.88
Antioxidant pathways in Alzheimer's disease: possibilities of intervention. Curr Pharm Des (2011) 0.88
Lack of association between adipokines and ghrelin and carotid intima-media thickness in patients with severe rheumatoid arthritis. Clin Exp Rheumatol (2011) 0.88
Diagnostic approach in a patient presenting with polymyalgia. Clin Exp Rheumatol (1999) 0.87
Pyomyositis and septic arthritis from Fusobacterium nucleatum in a nonimmunocompromised adult. J Rheumatol (1993) 0.86
Bronchial asthma induced by chick pea and lentil. Allergy (1992) 0.85
Predictors of cerebrovascular accidents in giant cell arteritis in a defined population. Clin Exp Rheumatol (2004) 0.85
Temporal arteritis in a northwestern area of Spain: study of 57 biopsy proven patients. J Rheumatol (1992) 0.84
Adverse reactions to immunotherapy are associated with different patterns of sensitization to grass allergens. Allergy (2015) 0.83
Pistachio nut hypersensitivity: identification of pistachio nut allergens. Clin Exp Allergy (1993) 0.83
Lack of association of PTPN22, STAT4 and TRAF1/C5 gene polymorphisms with cardiovascular risk in rheumatoid arthritis. Clin Exp Rheumatol (2010) 0.83
Asthma and contact urticaria caused by rice in a housewife. Allergy (1994) 0.83
Lack of association between macrophage migration inhibitory factor-173 gene polymorphism with disease susceptibility and cardiovascular risk in rheumatoid arthritis patients from northwestern Spain. Clin Exp Rheumatol (2010) 0.83
Non-typhi Salmonella infection in patients with rheumatic diseases on TNF-alpha antagonist therapy. Clin Exp Rheumatol (2010) 0.82
Kikuchi's disease (necrotizing lymphadenitis) with cutaneous involvement associated with subacute cutaneous lupus erythematosus. Clin Exp Dermatol (2004) 0.82
Polymorphism at codon 469 of the intercellular adhesion molecule-1 locus is associated with protection against severe gastrointestinal complications in Henoch-Schönlein purpura. J Rheumatol (2001) 0.82
Hip pain. Ann Rheum Dis (1999) 0.81
Successful therapy with danazol in refractory autoimmune thrombocytopenia associated with rheumatic diseases. Br J Rheumatol (1997) 0.81
Colonic perforation in a patient with amyloidosis and ankylosing spondylitis. J Rheumatol (1994) 0.80
Lack of association of a functional single nucleotide polymorphism of PTPN22, encoding lymphoid protein phosphatase, with susceptibility to Henoch-Schönlein purpura. Clin Exp Rheumatol (2007) 0.80
Sciatic nerve palsy as presenting sign of a perianal abscess. Joint Bone Spine (2003) 0.79
Inflammation and endothelial dysfunction in rheumatoid arthritis. Clin Exp Rheumatol (2006) 0.79
Investigation of CD69 as a new candidate gene for rheumatoid arthritis. Tissue Antigens (2008) 0.79
Lack of association between intercellular adhesion molecule-1 gene polymorphisms and giant cell arteritis. J Rheumatol (2001) 0.78
Luberculous spondylitis: epidemiologic and clinical study in non-HIV patients from northwest Spain. Clin Exp Rheumatol (2002) 0.78
Lack of association between macrophage migration inhibitory factor gene (-173 G/C) polymorphism and cutaneous vasculitis. Clin Exp Rheumatol (2006) 0.78
Regulated upon activation normal T-cell expressed and secreted (RANTES) and epithelial cell-derived neutrophil-activating peptide (ENA-78) gene polymorphisms in patients with biopsy-proven erythema nodosum. Clin Exp Rheumatol (2009) 0.78
Lack of association between A561C E-selectin polymorphism and large and small-sized blood vessel vasculitides. Clin Exp Rheumatol (2002) 0.77
Lack of association between interleukin-6 promoter polymorphism at position -174 and Henoch-Schönlein pur pura. Clin Exp Rheumatol (2007) 0.77
Systemic lupus erythematosus and Crohn's disease: an uncommon association of two autoimmune diseases. Clin Exp Rheumatol (2004) 0.77
Biopsy-proven giant cell arteritis patients with coronary artery disease have increased risk of aortic aneurysmal disease and arterial thrombosis. Clin Exp Rheumatol (2013) 0.77
Anti-endothelial cell antibodies and biopsy-proven temporal arteritis. Lupus (2002) 0.77
Implication of the age in the clinical spectrum of giant cell arteritis. Clin Exp Rheumatol (2008) 0.77
Influence of MHCIITA rs3087456 and rs4774 polymorphisms in the susceptibility to cardiovascular disease of patients with rheumatoid arthritis. Clin Exp Rheumatol (2012) 0.77
Low back pain as presenting manifestation of giant cell arteritis associated to abdominal aortitis. Clin Exp Rheumatol (2007) 0.77
Bilateral vertebral artery occlusion in giant cell arteritis. Clin Exp Rheumatol (2006) 0.77
E-selectin polymorphism in erythema nodosum secondary to sarcoidosis. Clin Exp Rheumatol (2004) 0.77
Association study of ghrelin receptor gene polymorphisms in rheumatoid arthritis. Clin Exp Rheumatol (2010) 0.76
TNF +489 polymorphism does not contribute to susceptibility to rheumatoid arthritis. Clin Exp Rheumatol (2003) 0.76
Henoch-Schönlein purpura as clinical presentation of a myelodysplastic syndrome. Clin Rheumatol (1997) 0.76
Lack of association between IL-1 cluster and TNF-alpha gene polymorphisms and giant cell arteritis. Clin Exp Rheumatol (2002) 0.76
Generalized granuloma annulare and giant cell arteritis. Clin Exp Rheumatol (2008) 0.76
The quest for the ideal therapy for giant cell arteritis. Rev Rhum Engl Ed (1996) 0.75
[Arthritis reactive to Giardia lamblia]. Med Clin (Barc) (1992) 0.75
Cutaneous vasculitis and solid tumors. Rev Rhum Engl Ed (1999) 0.75
[Encephalopathy caused by phenytoin]. Med Clin (Barc) (1992) 0.75
HLA-DRB1*04 may be a marker of severity in giant cell arteritis. Ann Rheum Dis (2000) 0.75
Hepatic arteritis in Behçet's disease. J Rheumatol (1991) 0.75
Magnetic resonance imaging: a useful technique in the diagnosis and follow up of focal myositis. Ann Rheum Dis (1996) 0.75
[Clindamycin desensitization in a patient with the acquired immunodeficiency syndrome]. Med Clin (Barc) (1992) 0.75
Rheumatic manifestations as presenting signs of infective endocarditis. Clin Exp Rheumatol (2002) 0.75
Henoch-Schönlein purpura in adults and autoimmune thyroiditis. J Rheumatol (2000) 0.75
Giant cell arteritis in Mediterranean countries: comment on the article by Salvarani et al. Arthritis Rheum (1992) 0.75
Giant cell arteritis and amyloidosis: comment on the article by Salvarani et al. Arthritis Rheum (1996) 0.75
The use of carotid ultrasonography in the assessment of subclinical atherosclerosis and the paradoxical effect of corticosteroids on atherosclerosis in patients with rheumatoid arthritis. Clin Exp Rheumatol (2009) 0.75
Systemic lupus erythematosus and ulcerative colitis: an uncommon association. Clin Exp Rheumatol (1998) 0.75
Towards a new clinical spectrum in giant cell arteritis. Clin Rheumatol (1997) 0.75
Baker's cyst as a clinical presentation of brucellosis. Clin Infect Dis (1996) 0.75
Serum sickness-like syndrome associated with cefaclor therapy. Allergy (1992) 0.75
[Reactive arthritis and infestation by Giardia lamblia]. Rev Esp Enferm Dig (1991) 0.75
A case-control study suggests that the CCR6 locus is not involved in the susceptibility to giant cell arteritis. Clin Exp Rheumatol (2013) 0.75
Atypical Baker's cyst as a presenting sign of osteomyelitis superimposed on avascular necrosis of the knee. Clin Exp Rheumatol (2002) 0.75
[Comparative study of von Willebrand factor in patients with temporal arteritis]. An Med Interna (1992) 0.75
[Rhabdomyolysis as a form of presentation of polymyositis]. An Med Interna (1992) 0.75
[Post-streptococcal reactive arthritis versus rheumatic fever]. Rev Clin Esp (1992) 0.75
[Vertebral pedicle hypoplasia associated with sciatic syndrome]. An Med Interna (1992) 0.75